TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Provision of Lateral Flow testing devices for the detection of COVID-19 viral antigens

Diagnostic kits
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency: "Provision of Lateral Flow testing devices for the detection of COVID-19 viral antigens". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthoritySecretary of State for Health and Social Care acting as part of the Crown through UK Health Security AgencyScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
3.1Bids / Report
61% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 134 active published awards; 82 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published24 Jan 2022, 15:00 GMT
Last source update24 Jan 2022, 15:00 GMT
Recurring procurementNot published
ClassificationDiagnostic kits
Delivery area
UK
OCIDocds-h6vhtk-030e89
What is being bought
The Omicron outbreak and its high transmissibility has however led to an urgent and unforeseeable surge in demand for LFTs. Due to this urgency, UKHSA is unable to comply with the time periods required for a further competitive tender (whether under the DPS or otherwise), as any delay will risk the current stock of competitively-procured LFTs being exhausted thereby introducing a significant risk to public health. <br/>UKHSA has therefore used the negotiated procedure without prior publication under Regulation 32(2)(c) of the Public Contracts Regulations 2015 to award a contract to Tanner Pharma UK LImited on 29 December 2021 for £169,000,000.
What changed
From the official release history
  1. Status changed to complete
    24 Jan 2022, 15:00 GMT
  2. Official notice release published
    24 Jan 2022, 15:00 GMT
  3. Buyer information updated
    24 Jan 2022, 15:00 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    The Omicron outbreak and its high transmissibility has however led to an urgent and unforeseeable surge in demand for LFTs. Due to this urgency, UKHSA is unable to comply with the time periods required for a further competitive tender (whether under the DPS or otherwise), as any delay will risk the current stock of competitively-procured LFTs being exhausted thereby introducing a significant risk to public health. <br/>UKHSA has therefore used the negotiated procedure without prior publication under Regulation 32(2)(c) of the Public Contracts Regulations 2015 to award a contract to Tanner Pharma UK LImited on 29 December 2021 for £169,000,000.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    24 Jan 2022, 15:00 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 3 Sept 2021, 00:00 BST · Not published
Commercial outcome and competition
Awards
TANNER PHARMA UK LIMITED
Not published · Not published · active
Contracts
Contract
Not published · signed 3 Sept 2021, 00:00 BST · active
Bid statistics
bids: 1 (lot 1)
highestValidBidValue: 169000000 (lot 1)
lowestValidBidValue: 169000000 (lot 1)
Buyer and organisations in this procedure

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

Contracting authority GB-FTS-34582
View buyer profile
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleMass testing using lateral flow testing kits (LFTs) for the detection of Covid-19 viral antigens has become a key part of protecting the economy and saving lives during the Covid-19 pandemic. UKHSA has ensured the supply of LFTs by implementing a Dynamic Purchasing System (as advertised in a contract notice on the Find a Tender Service with reference C22033 on 5 March 2021) and procuring LFTs competitively through that DPS. A further competitive tender through the DPS is currently in progress. <br/>The Omicron outbreak and its high transmissibility has however led to an urgent and unforeseeable surge in demand for LFTs. Due to this urgency, UKHSA is unable to comply with the time periods required for a further competitive tender (whether under the DPS or otherwise), as any delay will risk the current stock of competitively-procured LFTs being exhausted thereby introducing a significant risk to public health. <br/>UKHSA has therefore used the negotiated procedure without prior publication under Regulation 32(2)(c) of the Public Contracts Regulations 2015 to award a contract to Tanner Pharma UK LImited on 29 December 2021 for £169,000,000.